scPanel: a tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets
Briefings in Bioinformatics · 23.09.2024 · 25 (6)
DOI: 10.1093/bib/bbae482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 30.09.2024. Verfasst von Yi Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Programme in Cardiovascular and Metabolic Disorders, Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Sin…. Hauptthemen laut MEDLINE: COVID-19, Single-Cell Analysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Singapore Ministry of Education, Singapore National Medical Research Council, Enrico Petretto and Singapore National Medical Research Council.
Abstract (Originalsprache)
Single-cell RNA sequencing (scRNA-seq) technologies can generate transcriptomic profiles at a single-cell resolution in large patient cohorts, facilitating discovery of gene and cellular biomarkers for disease. Yet, when the number of biomarker genes is large, the translation to clinical applications is challenging due to prohibitive sequencing costs. Here, we introduce scPanel, a computational framework designed to bridge the gap between biomarker discovery and clinical application by identifying a sparse gene panel for patient classification from the cell population(s) most responsive to perturbations (e.g. diseases/drugs). scPanel incorporates a data-driven way to automatically determine a minimal number of informative biomarker genes. Patient-level classification is achieved by aggregating the prediction probabilities of cells associated with a patient using the area under the curve score. Application of scPanel to scleroderma, colorectal cancer, and COVID-19 datasets resulted in high patient classification accuracy using only a small number of genes (<20), automatically selected from the entire transcriptome. In the COVID-19 case study, we demonstrated cross-dataset generalizability in predicting disease state in an external patient cohort. scPanel outperforms other state-of-the-art gene selection methods for patient classification and can be used to identify parsimonious sets of reliable biomarker candidates for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Programme in Cardiovascular and Metabolic Disorders, Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
- The School of Mechanical and Aerospace Engineering and the School of Electrical and Electronic Engineering, Nanyang Technological University, 50 Nanyang Ave, Singapore 639798, Singapore.
ORCID-Profile: Yi Xie, Jianfei Yang, John F Ouyang, Enrico Petretto
Förderung
- Singapore Ministry of Education
- Singapore National Medical Research Council
- Enrico Petretto and Singapore National Medical Research Council
Zitieren
APA
Xie, Y., Yang, J., Ouyang, J. F., & Petretto, E. (2024). scPanel: a tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets. Briefings in Bioinformatics, 25(6). https://doi.org/10.1093/bib/bbae482
Vancouver
Xie Y, Yang J, Ouyang JF, Petretto E. scPanel: a tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets. Briefings in Bioinformatics. 2024;25(6). doi:10.1093/bib/bbae482
BibTeX
@article{Xie2024,
author = {Xie, Yi and Yang, Jianfei and Ouyang, John F and Petretto, Enrico},
title = {scPanel: a tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {6},
doi = {10.1093/bib/bbae482}
}
EUVIMED